Compare Live Nation Entertainment, Inc. (LYV) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Live Nation Entertainment, Inc. vs Zoetis Inc — how do they compare? Live Nation Entertainment, Inc. trades at $180.98 (market cap $42.09B), while Zoetis Inc trades at $75.47 (market cap $31.95B). The key difference: Live Nation Entertainment, Inc. is the larger of the two by market cap, and Zoetis Inc pays a 2.78% dividend while Live Nation Entertainment, Inc. pays none. Which is the better fit depends on your goals.
| LYV | ZTS | |
|---|---|---|
Market Cap | $42.09B | $31.95B |
Sector | Industrials | Health |
52-Week High | $186.59 | $156.76 |
52-Week Low | $125.61 | $71.91 |
Enterprise Value | $43.59B | $39.24B |
Dividend Yield | — | 2.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Live Nation (LYV) trades at $177.83, down 1.33% on the day, with a bullish technical signal from moving averages but neutral oscillators. The company reported $25.20B revenue for 2025 with a slim 0.33% net margin, while recent earnings misses have pressured sentiment. Strong cash flow from operations of $1.40B supports ongoing investments in live events, with analyst consensus overwhelmingly bullish at 88.6% buy ratings.
Outlook remains positive due to resilient live event demand and projected 2026 revenue growth to $25.60B, though risks include high valuation multiples (P/E 117.5), recent earnings misses, and sensitivity to consumer discretionary spending. The consensus price target of $201.50 suggests 13% upside potential from current levels.
Zoetis (ZTS) trades at $75.33, down 1.61% amid mixed technical signals and ongoing securities litigation. The stock shows strong fundamentals with a 28.03% net margin and 67.75% ROE, supported by consistent revenue growth from $8.1B in 2022 to $9.47B in 2025. Recent earnings beat expectations in Q3 and Q4 2025 but missed in Q1 2026, with Q2 results pending. Analyst consensus remains positive with a $101.43 price target, though technical indicators show neutral momentum near key support at $75.
The outlook for ZTS is cautiously optimistic given robust profitability and analyst support, but significant legal overhangs and recent earnings volatility present near-term risks. Long-term growth in animal health markets offers upside, yet investors should monitor litigation developments and Q2 earnings for directional cues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Live Nation Entertainment, Inc.
Live Nation is the largest live entertainment firm in the world with over 570 million fans served in 44 countries in 2018 by the company's concert and ticketing platforms. Via either owning, operating, or holding exclusive booking rights, Live Nation controls over 235 venues including the House of Blues, the Hollywood Palladium, and Spark Arena in New Zealand. Live Nation also owns one of the largest ticketing services, Ticketmaster, which sold over 480 million tickets for over 12,000 clients in 2018. The firm's artist management agencies have over 400 clients. This large live entertainment footprint helped Live Nation become one of the largest advertising and sponsorship platforms aimed at music fans. Liberty Media owns 33% of Live Nation, held under its SiriusXM tracking stock.
Read more on LYV →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
